Page 2 - Research Award Program News Today

Research brief: In a lab study, a UCLA-led team found that verteporfin stopped the replication of SARS-CoV-2, the virus that causes COVID-19.

Women with COVID in pregnancy who are subsequently vaccinated after recovery, but prior to delivery, are more likely to pass antibodies on to the child than similarly infected but unvaccinated mothers are.

Company operating well through unprecedented global economic headwinds and continued impacts of COVID-19 variants in certain markets Q2'22 total revenues

Press release content from Business Wire. The AP news staff was not involved in its creation.

The findings suggested that viral polymerase could potentially be added to vaccines to create a longer-lasting immune response

The findings suggested that viral polymerase could potentially be added to vaccines to create a longer-lasting immune response

Researchers have found rare naturally occurring T cells that are capable of targeting a protein found in SARS-CoV-2 and a range of other coronaviruses.

Researchers have found rare naturally occurring T cells that are capable of targeting a protein found in SARS-CoV-2 and a range of other coronaviruses.

Researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have identified rare, naturally occurring T cells that are capable of targeting a protein found in SARS-CoV-2 and a range of other coronaviruses.

Tamra Burns Loeb’s profile on The Conversation